Polivy

Made by

• Chugai (Roche)

Active Ingredient

Polatuzumab vedotin (genetical recombination)

Prospectus

Approval date

2021/3/23

Treats

• Diffuse large B-cell lymphoma, not otherwise specified

Dosages

• POLIVY for Intravenous Infusion - 298825円／瓶

• POLIVY for Intravenous Infusion - 1364330円／瓶